Clinical trials recruiting for Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
4
Recruiting trials
2
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 3Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Active Surveillance | 1 |
| Levetiracetam (Keppra) | 1 |
| Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 2 |
| Vermont | 1 |
Top cities
Self-screener
Recruiting trials
- Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial
- Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases
- Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
- Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
Related conditions
Trials recruiting for Brain Metastases From Non-small Cell Lung Cancer (NSCLC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Brain Metastases From Non-small Cell Lung Cancer (NSCLC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.